Ocera Therapeutics, Inc.
OCRX
OCRX was delisted on the 8th of December, 2017.
41 hedge funds and large institutions have $46M invested in Ocera Therapeutics, Inc. in 2014 Q4 according to their latest regulatory filings, with 15 funds opening new positions, 8 increasing their positions, 8 reducing their positions, and 3 closing their positions.
400% more first-time investments, than exits
New positions opened: 15 | Existing positions closed: 3
34% more capital invested
Capital invested by funds: $34.4M → $46M (+$11.6M)
32% more funds holding
Funds holding: 31 → 41 (+10)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
0% more repeat investments, than reductions
Existing positions increased: 8 | Existing positions reduced: 8
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SM
Sabby Management
Miami Beach,
Florida
|
+$2.52M |
| 2 |
GPP
Great Point Partners
Greenwich,
Connecticut
|
+$611K |
| 3 |
SFM
Sphera Funds Management
Tel Aviv,
Israel
|
+$585K |
| 4 |
JP Morgan Chase
New York
|
+$365K |
| 5 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
+$165K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PAAMCP
Pacific Alternative Asset Management Company (PAAMCO)
Irvine,
California
|
-$1.09M |
| 2 |
TI
Turner Investments
Berwyn,
Pennsylvania
|
-$857K |
| 3 |
QF
QVT Financial
New York
|
-$342K |
| 4 |
Millennium Management
New York
|
-$335K |
| 5 |
DCM
DAFNA Capital Management
Los Angeles,
California
|
-$238K |
OCRX Hedge Fund Activity: Q4 2014 in Review
41 of the 3,751 institutional investors tracked by Wall St. Rank reported a position in Ocera Therapeutics, Inc. (OCRX) for Q4 2014, worth a combined $46M — up 34% from $34.4M a quarter earlier.
Buyers outnumbered sellers: 15 funds opened new OCRX positions and 3 closed out — a net gain of 12 holders — while 8 added to existing stakes and 8 trimmed.
The largest buyer was Sabby Management, opening a new position worth an estimated $2.52M. The largest seller was Pacific Alternative Asset Management Company (PAAMCO), exiting entirely with an estimated $1.09M sold.
- 41 institutional investors held Ocera Therapeutics, Inc. (OCRX) as of Q4 2014, up from 31 in Q3 2014.
- Funds reported $46M of Ocera Therapeutics, Inc. stock for Q4 2014, up 34% quarter-over-quarter.
- 15 funds opened new Ocera Therapeutics, Inc. positions in Q4 2014 and 3 closed out, a net change of +12 holders.
- The largest Ocera Therapeutics, Inc. buyer in Q4 2014 was Sabby Management, an estimated $2.52M added.
- The largest Ocera Therapeutics, Inc. seller in Q4 2014 was Pacific Alternative Asset Management Company (PAAMCO), an estimated $1.09M sold.
Based on aggregated 13F filings for Q4 2014.